Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

BRCA1/2 Mutation × rocakinogene sifuplasmid × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 2 Stomach Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Hepatitis, Chronic 1 Hepatitis C 1 Head and Neck Squamous Cell Cancer 1 Head and Neck Neoplasms 1 Glioblastoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1 BRCA1/2 Mutation 1

Interventions

rocakinogene sifuplasmid 1 Mastectomy, Segmental 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04367675 2026-02-23

INO 5401 Vaccination in BRCA1/2 Mutation Carriers

Abramson Cancer Center at Penn Medicine

Phase 1 Active not recruiting

BRCA1/2 Mutation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡